The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report
Open accessAbstract
The most advantageous combination of immunosuppressive agents for cardiac transplant recipients has not yet been established. Between November 2001 and June 2003, 343 de novo cardiac transplant recipients were randomized to receive steroids and either tacrolimus (TAC) + sirolimus (SRL), TAC + mycophenolate mofetil (MMF) or cyclosporine (CYA) + MMF. Antilymphocyte induction therapy was allowed for up to 5 days. The primary endpoint of >/=3A rejection or hemodynamic compromise rejection requiring treatment showed no significant difference at 6 months (TAC/MMF 22.4%, TAC/SRL 24.3%, CYA/MMF 31.6%, p = 0.271) and 1 year (p = 0.056), but it was significantly lower in the TAC/MMF group when compared only to the CYA/MMF group at 1 year (23.4% vs. 36.8%; p = 0.029). Differences in the incidence of any treated rejection were significant (TAC/SRL = 35%, TAC/MMF = 42%, CYA/MMF = 59%; p < 0.001), as were median levels of serum creatinine (TAC/SRL = 1.5 mg/dL, TAC/MMF = 1.3 mg/dL, CYA/MMF = 1.5 mg/dL; p = 0.032) and triglycerides (TAC/SRL = 162 mg/dL, TAC/MMF = 126 mg/dL, CYA/MMF = 154 mg/dL; p = 0.028). The TAC/SRL group encountered fewer viral infections but more fungal infections and impaired wound healing. These secondary endpoints suggest that the TAC/MMF combination appears to offer more advantages than TAC/SRL or CYA/MMF in cardiac transplant patients, including fewer >/=3A rejections or hemodynamic compromise rejections and an improved side-effect profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Billingham, M. E., Cary, N. R. B., Hammond, M. E. H., Kemnitz, J., Marboe, C. C., Mccallister, H. A., Snovar, D. C., Winters, G. L., & Zerbe, A. (1990) · PubMed · Cited by 1,490
Effect of pravastatin on outcomes after cardiac transplantation
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301 · cited 1×
“The comparable use of statins among treatment groups in this study is important to differentiating an effect specific to TAC, as statin therapy not only inhibits cholesterol production, but can also reduce the incidence of cardiac allograft vasculopathy and hemodynamic compromise rejection and improve survival (20).”
BackgroundSelf-citationEisen, H. J., Tuzcu, E. M., Dorent, R., Kobashigawa, J., Mancini, D., Valantine-von Kaeppler, H. A., Starling, R. C., Sørensen, K., Hummel, M., Lind, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022171 · Cited by 1,198
Self-citationFK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
Starzl, T., Fung, J., Venkataramman, R., Todo, S., Demetris, A., & Jain, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91014-3 · Cited by 1,035
A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1
Kobashigawa, J., Miller, L., Renlund, D., Mentzer, R., Alderman, E., Bourge, R., Costanzo, M., Eisen, H., Dureau, G., Ratkovec, R., et al. (1998) · Transplantation · doi:10.1097/00007890-199808270-00016 · Cited by 615
Self-citationKeogh, A., Richardson, M., Ruygrok, P., Spratt, P., Galbraith, A., O’Driscoll, G., Macdonald, P., Esmore, D., Muller, D., & Faddy, S. (2004) · Circulation · doi:10.1161/01.cir.0000136812.90177.94 · Cited by 463
Hertz, M. I., Taylor, D. O., Trulock, E. P., Boucek, M. M., Mohacsi, P. J., Edwards, L. B., & Keck, B. M. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00498-9 · Cited by 360
Plosker, G. L., & Foster, R. H. (2000) · Drugs · doi:10.2165/00003495-200059020-00021 · Cited by 343
Taylor, D. O., Barr, M. L., Radovancevic, B., Renlund, D. G., Mentzer Jr, R. M., Smart, F. W., Tolman, D. E., Frazier, O. H., Young, J. B., & VanVeldhuisen, P. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(98)00060-6 · Cited by 318
Pham, S. M., Kormos, R. L., Hattler, B. G. J., Kawai, A., Tsamandas, A. C., Demetris, A. J., Murali, S., Fricker, F. J., Chang, H. C., Jain, A. B., et al. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70336-7 · Cited by 158
Reichart, B., Meiser, B., Viganò, M., Rinaldi, M., Martinelli, L., Yacoub, M. H., Banner, N. R., Gandjbakhch, I., Dorent, R., Hetzer, R., et al. (1998) · PubMed · Cited by 152
Escobar, A., Ventura, H. O., Stapleton, D. D., Mehra, M. R., Ramee, S. R., Collins, T. J., Jain, S. P., Smart, F. W., & White, C. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90856-7 · Cited by 98
Meiser, B., Überfuhr, P., Fuchs, A., Schmidt, D., Pfeiffer, M. M., Paulus, D., Schulze, C., Wildhirt, S. M., von Scheidt, W., Angermann, C. E., et al. (1998) · PubMed · Cited by 89
Heart transplantation in patients with diabetes mellitus in the current era
Marelli, D., Laks, H., Patel, B., Kermani, R., Marmureanu, A., Patel, J. K., & KOBASHIGAWA, J. A. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01219-6 · Cited by 73
Self-citationLongitudinal study of vascular remodeling in coronary arteries after heart transplantation
KOBASHIGAWA, J. A., Wener, L. S., Johnson, J., Currier, J. W., Yeatman, L. A., Cassem, J. D., & Tobis, J. M. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00100-5 · Cited by 61
Self-citationPiva, M. G., Navaglia, F., Basso, D., Fogar, P., Roveroni, G., Gallo, N., Zambon, C., Pedrazzoli, S., & Plebani, M. (2000) · Oncology · doi:10.1159/000012190 · Cited by 56
Morbidity and mortality in diabetic patients following cardiac transplantation
Lang, C. C., Beniaminovitz, A., Edwards, N. M., & MANCINI, D. M. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00567-3 · Cited by 44
Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol
Baran, D. A., Galin, I. D., Sandler, D. A., Segura, L. G., Cheng, J. W. M., Courtney, M. C., Correa, R., Chan, M. C., Fallon, J. T., Spielvogel, D., et al. (2002) · Transplantation · doi:10.1097/00007890-200210270-00014 · Cited by 29
Cited by
Costanzo, M. R., Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,653
Self-citationCalcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
Brunet, M., van Gelder, T., Åsberg, A., Haufroid, V., Hesselink, D. A., Langman, L., Lemaitre, F., Marquet, P., Seger, C., Shipkova, M., et al. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000640 · Cited by 707
Velleca, A., Shullo, M. A., Dhital, K., Azeka, E., Colvin, M., DePasquale, E., Farrero, M., García-Guereta, L., Jamero, G., Khush, K., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.015 · Cited by 645
Self-citationCardiac Allograft Vasculopathy: Recent Developments
Schmauss, D., & Weis, M. (2008) · Circulation · doi:10.1161/circulationaha.107.711911 · Cited by 587
Metadata
- Authors
- Kobashigawa, J. A., Miller, L. W., Russell, S. D., Ewald, G. A., Zucker, M. J., Goldberg, L. R., Eisen, H. J., Salm, K., Tolzman, D., Gao, J., Fitzsimmons, W., & First, R.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 6
- Issue
- 6
- Pages
- 1377-1386
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2043851911
- Cited by
- 329
- References
- 18
- FWCI
- 23.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.